Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia.
Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Tygerberg Campus 8000, Cape Town, South Africa rae@sun.ac.za.
Robin
R
Emsley
Department of Psychiatry and Psychotherapy, Medical University Innsbruck, Innsbruck, Austria.
W Wolfgang
WW
Fleischhacker
Department of Psychiatry, University of Naples, Naples, Italy.
Silvana
S
Galderisi
Vinfen, Cambridge, MA, USA.
Lisa J
LJ
Halpern
Department of Psychiatry and Health Behavior, Georgia Regents University, Augusta, Georgia, USA.
Joseph P
JP
McEvoy
State University of New York, Brooklyn, NY, USA.
Nina R
NR
Schooler
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000941:ethics / Q000379:methods*; D004335:Drug and Narcotic Control / Q000379:methods; D006801:Humans; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy*; D055502:Secondary Prevention / Q000941:ethics / Q000379:methods*
D014150:Antipsychotic Agents; D010919:Placebos